Paul Tudor Jones's CAI Position Overview
Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 182,382 shares of Caris Life Sciences, Inc. (CAI) worth $4.92 M, representing 0.01% of the portfolio. First purchased in 2025-Q2, this short-term holding has been held for 3 quarters.
Based on 13F filings, Paul Tudor Jones has maintained this position in CAI for several quarters, showing initial confidence in the investment. Largest reduction occurred in Q4 2025, reducing 82,169 shares.
Analysis based on 13F filings available since 2013 Q2
Paul Tudor Jones's Caris Life Sciences (CAI) Holding Value Over Time
Track share changes against reported price movement
Quarterly Caris Life Sciences (CAI) Trades by Paul Tudor Jones
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -82,169 | Reduce 31.06% | 182,382 | $26.98 |
| Q2 2025 | +264,551 | New Buy | 264,551 | $26.72 |
Paul Tudor Jones's Caris Life Sciences Investment FAQs
Paul Tudor Jones first purchased Caris Life Sciences, Inc. (CAI) in Q2 2025, acquiring 264,551 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones has held Caris Life Sciences, Inc. (CAI) for 3 quarters since Q2 2025.
Paul Tudor Jones's largest addition to Caris Life Sciences, Inc. (CAI) was in Q2 2025, adding 264,551 shares worth $7.07 M.
According to the latest 13F filing for Q4 2025, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 182,382 shares of Caris Life Sciences, Inc. (CAI), valued at approximately $4.92 M.
As of the Q4 2025 filing, Caris Life Sciences, Inc. (CAI) represents approximately 0.01% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings.
Paul Tudor Jones's peak holding in Caris Life Sciences, Inc. (CAI) was 264,551 shares, as reported at the end of Q2 2025.